Synthesis And Pharmacological Validation Of Novel Neuroprotective Purinergic Receptor P2X4 Antagonists For The Treatment Of Ischemic Stroke

被引:0
作者
Verma, Rajkumar
Toti, Kiran S.
Turro, Daylin Gamiotea
Wen, Zhiwei
Lewicki, Sarah
Jacobson, Kenneth
Liang, Bruce T.
机构
关键词
D O I
10.1161/str.54.suppl_1.41
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A41
引用
收藏
页数:2
相关论文
共 50 条
[11]   Interaction of Purinergic P2X4 and P2X7 Receptor Subunits [J].
Schneider, Markus ;
Prudic, Kirsten ;
Pippel, Anja ;
Klapperstueck, Manuela ;
Braam, Ursula ;
Mueller, Christa E. ;
Schmalzing, Guenther ;
Markwardt, Fritz .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[12]   P2x4 purinergic receptors: A novel therapeutic function in the treatment of heart failure [J].
Liang, BT ;
Pappano, A ;
Jones, L ;
Barry, W .
CIRCULATION, 2003, 108 (17) :206-206
[13]   Involvement of the purinergic P2X4 receptor in Alzheimer's disease [J].
Hua, J. ;
Rassendren, F. ;
Ulmann, L. .
GLIA, 2017, 65 :E196-E196
[14]   Heavy metals modulate the activity of the purinergic P2X4 receptor [J].
Coddou, C ;
Lorca, RA ;
Acuña-Castillo, C ;
Grauso, M ;
Rassendren, F ;
Huidobro-Toro, JP .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 202 (02) :121-131
[15]   Effect of Age and Stroke on Purinergic Receptor P2x4 (p2x4r) Expression in Human Monocyte Subsets [J].
Verma, Rajkumar ;
DiMauro, Sharon E. ;
Blumenfeld, Leslie ;
Srivastava, Pranay ;
Mittal, Sanjay ;
Bulsara, Ketan R. ;
Liang, Bruce T. .
STROKE, 2021, 52
[16]   Role of purinergic receptor P2X4 in experimental autoimmune encephalomyelitis [J].
Zabala, A. ;
Vazquez-Villoldo, N. ;
Gejo, J. ;
Rissiek, B. ;
Palomino, A. ;
Perez-Samartin, A. ;
Capetillo-Zarate, E. ;
Magnus, T. ;
Koch-Nolte, F. ;
Rassendren, F. ;
Matute, C. ;
Domercq, M. .
GLIA, 2017, 65 :E474-E475
[17]   Deficiency of the purinergic receptor P2X4 limits atherosclerosis in mice [J].
Koenig, S. ;
Peikert, A. ;
Merz, J. ;
Rofa, K. ;
Schaefer, I ;
Dimanski, D. ;
Karnbrock, L. ;
Von Garlen, S. ;
Aleid, R. ;
Bulatova, K. ;
Hoppe, N. ;
Bode, C. ;
Zirlik, A. ;
Stachon, R. .
EUROPEAN HEART JOURNAL, 2020, 41 :3795-3795
[18]   Piperazine-based P2X4 receptor antagonists [J].
Erlitz, Katharina Sophie ;
Siutkina, Alena I. ;
Prinz, Ann-Kathrin ;
Koch, Oliver ;
Kalinin, Dmitrii V. ;
Junker, Anna .
ARCHIV DER PHARMAZIE, 2025, 358 (01)
[19]   Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications? [J].
Witkin, Jeffrey M. ;
Shafique, Hana ;
Smith, Jodi L. ;
Cerne, Rok .
BIOCHEMICAL PHARMACOLOGY, 2024, 222
[20]   Pharmacological and genetic characterisation of the canine P2X4 receptor [J].
Sophocleous, Reece A. ;
Berg, Tracey ;
Finol-Urdaneta, Rocio K. ;
Sluyter, Vanessa ;
Keshiya, Shikara ;
Bell, Lachlan ;
Curtis, Stephen J. ;
Curtis, Belinda L. ;
Seavers, Aine ;
Bartlett, Rachael ;
Dowton, Mark ;
Stokes, Leanne ;
Ooi, Lezanne ;
Sluyter, Ronald .
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (12) :2812-2829